US · Healthcare · Medical Devices
EPS came in at -0.25 against a street estimate of -0.39 — a beat of 35.9%.
Analysts rate Avita Medical Ltd a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $12.08.
| Fund | Stake |
|---|---|
| Vanguard Capital Management, LLC | 4.31% |
| BlackRock Inc | 1.83% |
| Geode Capital Management, LLC | 1.10% |
| Marshall Wace Asset Management Ltd | 1.09% |
| AQR Capital Management LLC | 1.04% |
| Vanguard Fiduciary Trust Co | 0.59% |
| Morgan Stanley - Brokerage Accounts | 0.51% |
| Macquarie Group Ltd | 0.47% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Avita Medical Ltd — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.